Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight loss management. The San Francisco-based company, which…
Continue Reading
New Jersey-based nutritional supplements supplier The Vitamin Shoppe announced its launching of Whole Health Rx, a telehealth service that will connect users with providers to help them access GLP-1 medications for weight management. GLP-1s, or…
Continue Reading
Guy Friedman, co-founder and CEO of SteadyMD
The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same –…
Continue Reading
Dr. Stephanie Teotia, a distinguished board-certified plastic and reconstructive surgeon from Flower Mound, TX who serves patients in the Dallas area joins eHealth Radio and the Plastic Surgery Information Channel.
In today’s episode, Dr. Teotia,…
According to the CDC, 42% of Americans are considered obese. There aren’t enough obesity medicine specialists to see them all. Brand medications are on the FDA shortage list and natural methods such as diet…
Continue Reading
GLP-1 medications like Ozempic and Wegovy remain in high demand and continue to make headlines, even among mainstream media outlets. As the healthcare industry watches closely to see how payers decide to cover the…
Continue Reading
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have ushered in a new era for the weight loss market in 2024 and surfaced several questions that have been festering for quite some time and can…
Continue Reading
News and social media are saturated with articles about the demand for and shortage of glucagon-like peptide-1 (GLP-1) drugs marketed for weight loss. The best-known of these drugs is semaglutide, sold under the brand…
Continue Reading
What You Should Know: – Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst. –…
Continue Reading
George Kramb, CEO and co-founder of PatientPartner
You’ve probably heard about Ozempic, especially if you’re one of the millions who regularly scroll through TikTok or browse other social media platforms. It’s the drug that influencers…
Continue Reading
